Geode Capital Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$347K Buy
521,824
+423,473
+431% +$289K ﹤0.01% 3708
2025
Q4
$65K Buy
98,351
+51,813
+111% +$41K ﹤0.01% 4189
2025
Q3
$36.1K Sell
46,538
-47,593
-51% -$64.6K ﹤0.01% 4355
2025
Q2
$134K Sell
94,131
-101
-0.1% -$148 ﹤0.01% 3989
2025
Q1
$123K Buy
94,232
+6,511
+7% +$9.55K ﹤0.01% 3978
2024
Q4
$129K Sell
87,721
-823
-0.9% -$1.87K ﹤0.01% 4031
2024
Q3
$288K Buy
88,544
+1,585
+2% +$4.31K ﹤0.01% 3781
2024
Q2
$205K Sell
86,959
-3,017
-3% -$11.2K ﹤0.01% 3898
2024
Q1
$353K Buy
89,976
+32,647
+57% +$95.6K ﹤0.01% 3737
2023
Q4
$107K Buy
57,329
+42,637
+290% +$83.6K ﹤0.01% 4171
2023
Q3
$82.9K Sell
14,692
-4,387
-23% -$43.9K ﹤0.01% 4308
2023
Q2
$196K Hold
19,079
﹤0.01% 4053
2023
Q1
$192K Hold
19,079
﹤0.01% 4071
2022
Q4
$192K Hold
19,079
﹤0.01% 4125
2022
Q3
$187K Buy
19,079
+5,582
+41% +$54.8K ﹤0.01% 4253
2022
Q2
$132K Hold
13,497
﹤0.01% 4468
2022
Q1
$131K Buy
+13,497
New +$131K ﹤0.01% 4556

Other funds holding COCH

Geode Capital Management's COCH Position: Q1 2026 in Review

Geode Capital Management increased its Envoy Medical (COCH) stake by 431% in Q1 2026, buying an estimated $289K and bringing the position to 521,824 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #3708.

Geode Capital Management first reported a position in COCH in Q1 2022 and has held it in 17 quarters since. The position peaked at $353K in Q1 2024. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Geode Capital Management held 521,824 shares of Envoy Medical worth $347K as of Q1 2026.
  • Geode Capital Management bought 423,473 Envoy Medical shares in Q1 2026, an estimated $289K.
  • Envoy Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3708 holding.
  • Geode Capital Management first reported a position in Envoy Medical in Q1 2022 and has held it in 17 quarters since.
  • Geode Capital Management's Envoy Medical position peaked at $353K in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.